Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 05, 2019

SELL
$9.0 - $17.2 $234,000 - $447,200
-26,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$16.0 - $31.84 $192,000 - $382,080
12,000 Added 85.71%
26,000 $503,000
Q3 2018

Nov 08, 2018

BUY
$24.32 - $37.54 $97,280 - $150,160
4,000 Added 40.0%
14,000 $449,000
Q2 2018

Aug 09, 2018

BUY
$26.61 - $27.78 $266,100 - $277,800
10,000 New
10,000 $266,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $20.5M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Alpine Woods Capital Investors, LLC Portfolio

Follow Alpine Woods Capital Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.